300498:SZSEWen's Foodstuff Group Co., Ltd. Class A Analysis
Data as of 2026-09-10 - not real-time
CN¥15.06
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At ¥15.06, Wens Foodstuff Group Co., Ltd. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 5.2%. RSI sits at 63.8, which reads as approaching overbought, and MACD momentum is bullish. The recent range runs from support at ¥13.34 up to resistance at ¥15.49.
Valuation screens as undervalued, on a P/E of 11.9 with no clean sector comparison available. Sell-side targets cluster 27.4% above the current quote. Revenue is contracting at 12.5% on a -2.6% profit margin. The 3.29% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.8%, a beta of 0.07 and a maximum drawdown of 41.6%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Valuation screens as undervalued, on a P/E of 11.9 with no clean sector comparison available. Sell-side targets cluster 27.4% above the current quote. Revenue is contracting at 12.5% on a -2.6% profit margin. The 3.29% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.8%, a beta of 0.07 and a maximum drawdown of 41.6%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Understand the cash flow statement for Wens Foodstuff Group Co.Investing5monGuangdong Wens Foodstuff Group Co LtdEBITDA Multiple, Enterprise Value / EBITDA, or EV / EBITDA measures...Morningstar1yWens Foodstuff Group Co Ltd Class AWe sell different types of products and services to both investment...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 15.34
- MACD momentum is positive
- 30-day price change of +5.2%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 3.29% looks stretched against payout coverage
- Trading below the 200-day average of 15.34
- Analyst targets imply +27.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 3.29% looks stretched against payout coverage
- Negative profit margin of -2.6%
- Analyst targets imply +27.4% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-12.50%
Profit Margin-2.56%
P/E Ratio11.9
ROE-5.89%
ROA-1.27%
Debt/Equity74.57
P/B Ratio2.8
Op. Cash FlowCN¥5.8B
Free Cash FlowCN¥-7197406208
Technical Analysis
TrendNeutral
RSI63.8
SupportCN¥13.34
ResistanceCN¥15.49
MA 20CN¥14.29
MA 50CN¥13.97
MA 200CN¥15.34
MACDBullish
VolumeStable
Fear & Greed Index92.04
Valuation
Fair ValueCN¥4.48
Target PriceCN¥19.19
Upside/Downside27.40%
GradeUndervalued
TypeValue
Dividend Yield3.29%
Risk Assessment
Beta0.07
Volatility31.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.